DND | Jotup

Engine Capital Calls on Dye & Durham’s Board Not to Issue Shares Ahead of the Special Meeting

Retrieved on:

Lunedì, Maggio 6, 2024

Other Manufacturing, Manufacturing, Prospectus, Capital, Dye, TSX, Proxy, Attention, Toronto Stock Exchange, Exercise, DND, Acquisition, Special, Feedback, Security (finance)

Engine Capital LP (together with its affiliates, “Engine” or “we”) is a meaningful shareholder of Dye & Durham Limited (TSX: DND) (“Dye & Durham” or the “Company”), holding approximately 6.6% of the Company’s outstanding shares.

Key Points:

Engine Capital LP (together with its affiliates, “Engine” or “we”) is a meaningful shareholder of Dye & Durham Limited (TSX: DND) (“Dye & Durham” or the “Company”), holding approximately 6.6% of the Company’s outstanding shares.
On April 30, 2024, Dye & Durham filed a non-routine base shelf prospectus, which would facilitate the issuance of (among others) common shares of the Company.
Issuing shares at the current price would be a serious capital allocation mistake given the Company’s undervaluation.
Beyond this value destruction, issuing shares so close to the Special Meeting would be a governance stain on the Board and would disenfranchise the Company’s shareholders.

Oracle Advances Global RTSM Capabilities to Help Sponsors

Retrieved on:

Mercoledì, Maggio 1, 2024

FDA, Randomization, ChromeOS, DND, DCT, Clinical trial, Thrombectomy, Architecture, Pharmaceutical industry

BOSTON, May 1, 2024 /PRNewswire/ -- 6th Clinical Trial Supply Forum -- Helping sponsors and CROs meet the challenges of complex and global clinical trial studies, Oracle today announced new capabilities in Oracle Clinical One Randomization and Trial Supply Management (RTSM). With new enhancements for use, access, and regionalization, Clinical One RTSM users can address dynamic, country-specific regulations and requirements, and gain speed, reliability, and transparency of trials from commencement to closeout.

Key Points:

Latest updates to Oracle Clinical One RTSM cloud-based solution make it easier for sponsors and CROs to configure, scale, and automate to support complex and global clinical trial studies
BOSTON, May 1, 2024 /PRNewswire/ -- 6th Clinical Trial Supply Forum -- Helping sponsors and CROs meet the challenges of complex and global clinical trial studies, Oracle today announced new capabilities in Oracle Clinical One Randomization and Trial Supply Management (RTSM).
The new enhancements to the Oracle platform empower sponsors and CROs to be able to more easily tailor complex studies that can meet their global needs with speed and flexibility.
Oracle RTSM also has innovative built-in and enhanced reporting and analytics for real-time, cross-study analytics, and customized dashboards and visualizations.
To learn more about Oracle Clinical One Randomization and Trial Supply Management (RTSM) visit: https://www.oracle.com/life-sciences/clinical-research/clinical-one-rand...
Don't miss Oracle Life Sciences at the 6th Clinical Trial Supply Forum May 2-3 in Boston.

Engine Capital Issues Letter to Dye & Durham Shareholders Regarding Its Efforts to Improve Performance and Oversight

Retrieved on:

Giovedì, Aprile 25, 2024

Other Manufacturing, Manufacturing, Issuer, DND, Proxy, Dye

Even when synergies and pricing increases are taken into account, the multiples paid for acquisitions are still well above Dye & Durham’s current multiple.

Key Points:

Even when synergies and pricing increases are taken into account, the multiples paid for acquisitions are still well above Dye & Durham’s current multiple.
Mismanaging refinancing the Company’s C$345 million convertible: Despite the Company’s best efforts, this debenture is still outstanding and is now trading close to par.
This is an exorbitant number that reflects the frenetic pace of capital market activity under the current Board.
Such actions would only further underscore how the current directors are unfit to oversee Dye & Durham on behalf of shareholders.

CCC, U.S. Army sign agreement for ramp-up in ammunition production

Retrieved on:

Lunedì, Marzo 25, 2024

National security, UCA, Partnership, DFARS, DND, General Dynamics, CCC, Arms industry

The agreement will help address the growing requirements to meet the U.S. and allied commitments to Ukraine and strengthens the resiliency of the integrated Canada-U.S. defence supply chain.

Key Points:

The agreement will help address the growing requirements to meet the U.S. and allied commitments to Ukraine and strengthens the resiliency of the integrated Canada-U.S. defence supply chain.
Ukraine’s war effort depends heavily on 155mm artillery rounds supplied by Canada, the United States, and other allies.
This agreement underscores the profound interdependence of the US-Canada supply chain and highlights bilateral collaboration aimed at enhancing industrial capacity within the ammunition industry.
Under the Canada-U.S. Defence Production Sharing Agreement and DFARS 225.870, CCC acts as the designated contracting authority for U.S. DoD procurements from Canada.

International Test Pilots School (ITPS) Provides Tactical Training to Two Ukrainian Instructor Pilots and Receives Request from the Ukraine MOD to Train 30 More

Retrieved on:

Giovedì, Marzo 7, 2024

The Ukrainian Air Force has submitted a formal request with Canada's Department of National Defence to proceed with the training.

Key Points:

The Ukrainian Air Force has submitted a formal request with Canada's Department of National Defence to proceed with the training.
Two Ukrainian pilot instructors began training in October 2023 and have forged a productive collaboration with the Ivan Kozhedub National Air Force University (KNAFU) in Ukraine.
This fighter pilot training pipeline will be essential to ensure Ukrainian Air Force air superiority once new Western fighters are introduced.
ITPS Canada and its tactical training division the International Tactical Training Centre (ITTC) is a Canadian success story, as the world's largest independent school of flight test training.

Invicton Labs receives funding from Department of National Defence to develop automated, thermally-managed medical supply transport

Retrieved on:

Lunedì, Gennaio 29, 2024

CAF, Temperature, Security, DND, Innovation, National security, COVID-19, Idea, Instrumentation

OTTAWA, ON, Jan. 29, 2024 /PRNewswire-PRWeb/ -- Invicton Labs today announced that the company has been funded by the Department of National Defence (DND) to develop a transport device for temperature-sensitive medical supplies in extreme and austere environments. The funding is from the Innovation for Defence Excellence and Security (IDEaS) program, which is investing $1.6 billion in innovations for defence and security over 20 years.

Key Points:

OTTAWA, ON, Jan. 29, 2024 /PRNewswire-PRWeb/ -- Invicton Labs today announced that the company has been funded by the Department of National Defence (DND) to develop a transport device for temperature-sensitive medical supplies in extreme and austere environments.
The funding is from the Innovation for Defence Excellence and Security (IDEaS) program, which is investing $1.6 billion in innovations for defence and security over 20 years.
"We are demonstrating that small Canadian firms can compete at the highest level with, and demonstrate greater innovation than, multinational defence contractors."
We are demonstrating that small Canadian firms can compete at the highest level with, and demonstrate greater innovation than, multinational defence contractors."

Dye & Durham Announces Approximately $126 Million Bought Deal Offering of Common Shares

Retrieved on:

Mercoledì, Gennaio 17, 2024

Dye, Offerings, Person, Underwriting, Toronto Stock Exchange, DND, WIRE, Sale, TSX, Offering, NEWS, NOT, Security (finance)

The Company intends to use the net proceeds of the Offerings for the repayment of debt.

Key Points:

The Company intends to use the net proceeds of the Offerings for the repayment of debt.
The Offering is consistent with the Company's previously stated goal to delever the business.
Following closing of the Offering, the Company will have made significant progress towards its target of reducing its leverage ratio to less than four times total net debt to adjusted EBITDA .
No securities regulatory authority has either approved or disapproved the contents of this press release.

Ingenium acquires de Havilland Buffalo CC-115

Retrieved on:

Martedì, Novembre 28, 2023

The Buffalo is representative of both the technological developments of the time, and de Havilland Canada's legacy of designing short takeoff and landing airplanes for Canada's harsh climate.

Key Points:

The Buffalo is representative of both the technological developments of the time, and de Havilland Canada's legacy of designing short takeoff and landing airplanes for Canada's harsh climate.
The CC-115 Buffalo is a key addition to our RCAF and de Havilland collections.
We are thrilled to add the de Havilland Buffalo CC-115 to our national collection of science and innovation.
"Ingenium's acquisition of the de Havilland Buffalo CC-115 marks a pivotal moment in the narrative of Canadian aviation and 'Your Air Force.'

Voyageur Aviation Corp. Awarded Contract to Upgrade Canada's Department of National Defence CT-142 Fleet

Retrieved on:

Giovedì, Novembre 16, 2023

Atmosphere, Squadron, Navigation, Aviation, Growth, Voyageurs, DND, National security, AES, Airline

NORTH BAY, ON, Nov. 16, 2023 /CNW/ - Voyageur Aviation Corp. is pleased to announce that it has been awarded a contract with the Department of National Defence (DND) to provide several upgrades to their fleet of Dash 8-100 CT-142 aircraft.

Key Points:

NORTH BAY, ON, Nov. 16, 2023 /CNW/ - Voyageur Aviation Corp. is pleased to announce that it has been awarded a contract with the Department of National Defence (DND) to provide several upgrades to their fleet of Dash 8-100 CT-142 aircraft.
The award of this project further strengthens Voyageur's portfolio on special mission aircraft through innovative engineering services, heavy maintenance, parts & logistics support, as well as aircraft operations.
The Department of National Defence, at 402 Squadron in Winnipeg, operates a fleet of four CT-142 aircraft for the purpose of training Air Combat Systems Officers (ACSO) and Airborne Electronic Sensor (AES OP) Operators.
"The award of this contract supports our growth strategy of developing defence programs related to special mission aircraft services," said Carl Kumpic, Vice President, Defence & Government Programs.

Canadian Psychedelic Trade Association Endorses Senate Report Calling for Research into Psychedelic-Assisted Therapy

Retrieved on:

Mercoledì, Novembre 8, 2023

OTTAWA, Nov. 08, 2023 (GLOBE NEWSWIRE) -- PsyCan — the not-for-profit trade association of legally-operating Canadian psychedelic companies — enthusiastically endorses a new report by the Senate of Canada Subcommittee on Veteran Affairs urging federal, provincial, and territorial governments to launch and fund a large-scale research program into psychedelic-assisted therapy.

Key Points:

OTTAWA, Nov. 08, 2023 (GLOBE NEWSWIRE) -- PsyCan — the not-for-profit trade association of legally-operating Canadian psychedelic companies — enthusiastically endorses a new report by the Senate of Canada Subcommittee on Veteran Affairs urging federal, provincial, and territorial governments to launch and fund a large-scale research program into psychedelic-assisted therapy.
While Canada is a leader in developing these innovative treatments, many barriers remain to patient access, and government must play an active role.
“This report echoes our calls for government funding into psychedelic-assisted therapy,” said PharmAla Biotech CEO and PsyCan Chair Nick Kadysh.
“Research on these subjects is constantly evolving and will continue to do so.